These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 12788365)

  • 1. Peptide-based inhibitors of hepatitis C virus full-length NS3 (protease-helicase/NTPase): model compounds towards small molecule inhibitors.
    Oscarsson K; Poliakov A; Oscarson S; Danielson UH; Hallberg A; Samuelsson B
    Bioorg Med Chem; 2003 Jul; 11(13):2955-63. PubMed ID: 12788365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acyl sulfonamides as potent protease inhibitors of the hepatitis C virus full-Length NS3 (protease-helicase/NTPase): a comparative study of different C-terminals.
    Johansson A; Poliakov A; Akerblom E; Wiklund K; Lindeberg G; Winiwarter S; Danielson UH; Samuelsson B; Hallberg A
    Bioorg Med Chem; 2003 Jun; 11(12):2551-68. PubMed ID: 12757723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P1 Phenethyl peptide boronic acid inhibitors of HCV NS3 protease.
    Priestley ES; De Lucca I; Ghavimi B; Erickson-Viitanen S; Decicco CP
    Bioorg Med Chem Lett; 2002 Nov; 12(21):3199-202. PubMed ID: 12372533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of hepatitis C virus NS3 protease activity by product-based peptides is dependent on helicase domain.
    Johansson A; Hubatsch I; Akerblom E; Lindeberg G; Winiwarter S; Danielson UH; Hallberg A
    Bioorg Med Chem Lett; 2001 Jan; 11(2):203-6. PubMed ID: 11206459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-activity relationships for the selectivity of hepatitis C virus NS3 protease inhibitors.
    Poliakov A; Johansson A; Akerblom E; Oscarsson K; Samuelsson B; Hallberg A; Danielson UH
    Biochim Biophys Acta; 2004 Apr; 1672(1):51-9. PubMed ID: 15056493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent aza-peptide derived inhibitors of HCV NS3 protease.
    Venkatraman S; Wu W; Shih NY; George Njoroge F
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4760-3. PubMed ID: 19596195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highly potent and selective peptide-based inhibitors of the hepatitis C virus serine protease: towards smaller inhibitors.
    Llinàs-Brunet M; Bailey M; Fazal G; Ghiro E; Gorys V; Goulet S; Halmos T; Maurice R; Poirier M; Poupart MA; Rancourt J; Thibeault D; Wernic D; Lamarre D
    Bioorg Med Chem Lett; 2000 Oct; 10(20):2267-70. PubMed ID: 11055335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel potent macrocyclic inhibitors of the hepatitis C virus NS3 protease: use of cyclopentane and cyclopentene P2-motifs.
    Bäck M; Johansson PO; Wångsell F; Thorstensson F; Kvarnström I; Ayesa S; Wähling H; Pelcman M; Jansson K; Lindström S; Wallberg H; Classon B; Rydergård C; Vrang L; Hamelink E; Hallberg A; Rosenquist S; Samuelsson B
    Bioorg Med Chem; 2007 Nov; 15(22):7184-202. PubMed ID: 17845856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance profiling of hepatitis C virus protease inhibitors using full-length NS3.
    Dahl G; Sandström A; Akerblom E; Danielson UH
    Antivir Ther; 2007; 12(5):733-40. PubMed ID: 17713156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and biological activity of m-tyrosine-based 16- and 17-membered macrocyclic inhibitors of hepatitis C virus NS3 serine protease.
    Chen KX; Njoroge FG; Pichardo J; Prongay A; Butkiewicz N; Yao N; Madison V; Girijavallabhan V
    J Med Chem; 2005 Oct; 48(20):6229-35. PubMed ID: 16190750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanistic studies of electrophilic protease inhibitors of full length hepatic C virus (HCV) NS3.
    Poliakov A; Sandström A; Akerblom E; Danielson UH
    J Enzyme Inhib Med Chem; 2007 Apr; 22(2):191-9. PubMed ID: 17518346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus NS3/4A protease.
    Kwong AD; Kim JL; Rao G; Lipovsek D; Raybuck SA
    Antiviral Res; 1999 Feb; 41(1):67-84. PubMed ID: 10321580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Halogenated benzimidazoles and benzotriazoles as inhibitors of the NTPase/helicase activities of hepatitis C and related viruses.
    Borowski P; Deinert J; Schalinski S; Bretner M; Ginalski K; Kulikowski T; Shugar D
    Eur J Biochem; 2003 Apr; 270(8):1645-53. PubMed ID: 12694177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the C-terminal of hexapeptide inhibitors of the hepatitis C virus serine protease.
    Llinàs-Brunet M; Bailey M; Déziel R; Fazal G; Gorys V; Goulet S; Halmos T; Maurice R; Poirier M; Poupart MA; Rancourt J; Thibeault D; Wernic D; Lamarre D
    Bioorg Med Chem Lett; 1998 Oct; 8(19):2719-24. PubMed ID: 9873610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and antiviral evaluation of a novel series of homoserine-based inhibitors of the hepatitis C virus NS3/4A serine protease.
    Alexandre FR; Brandt G; Caillet C; Chaves D; Convard T; Derock M; Gloux D; Griffon Y; Lallos L; Leroy F; Liuzzi M; Loi AG; Moulat L; Musiu C; Parsy C; Rahali H; Roques V; Seifer M; Standring D; Surleraux D
    Bioorg Med Chem Lett; 2015 Sep; 25(18):3984-91. PubMed ID: 26231161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenylglycine as a novel P2 scaffold in hepatitis C virus NS3 protease inhibitors.
    Ortqvist P; Peterson SD; Kerblom E; Gossas T; Sabnis YA; Fransson R; Lindeberg G; Helena Danielson U; Karlén A; Sandström A
    Bioorg Med Chem; 2007 Feb; 15(3):1448-74. PubMed ID: 17113777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorous acid analogs of novel P2-P4 macrocycles as inhibitors of HCV-NS3 protease.
    Pompei M; Francesco ME; Koch U; Liverton NJ; Summa V
    Bioorg Med Chem Lett; 2009 May; 19(9):2574-8. PubMed ID: 19328685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide-based inhibitors of the hepatitis C virus NS3 protease: structure-activity relationship at the C-terminal position.
    Rancourt J; Cameron DR; Gorys V; Lamarre D; Poirier M; Thibeault D; Llinàs-Brunet M
    J Med Chem; 2004 May; 47(10):2511-22. PubMed ID: 15115394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tetrapeptides as potent protease inhibitors of Hepatitis C Virus full-length NS3 (protease-helicase/NTPase).
    Johansson A; Poliakov A; Akerblom E; Lindeberg G; Winiwarter S; Samuelsson B; Danielson UH; Hallberg A
    Bioorg Med Chem; 2002 Dec; 10(12):3915-22. PubMed ID: 12413843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity study on a novel series of macrocyclic inhibitors of the hepatitis C virus NS3 protease leading to the discovery of BILN 2061.
    Llinàs-Brunet M; Bailey MD; Bolger G; Brochu C; Faucher AM; Ferland JM; Garneau M; Ghiro E; Gorys V; Grand-Maître C; Halmos T; Lapeyre-Paquette N; Liard F; Poirier M; Rhéaume M; Tsantrizos YS; Lamarre D
    J Med Chem; 2004 Mar; 47(7):1605-8. PubMed ID: 15027850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.